Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research Network.
Saved in:
| Title: | Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research Network. |
|---|---|
| Authors: | Hainsworth JD; Sarah Cannon Cancer Center, 250 25th Avenue North, Nashville, TN 37203, USA. jhainsworth@tnonc.com, Burris HA 3rd, Billings FT 3rd, Bradof JE, Baker M, Greco FA |
| Source: | Cancer [Cancer] 2001 Nov 01; Vol. 92 (9), pp. 2391-8. |
| Publication Type: | Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Print ISSN: 0008-543X (Print) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 11745295 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research Network. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hainsworth+JD%22">Hainsworth JD</searchLink>; Sarah Cannon Cancer Center, 250 25th Avenue North, Nashville, TN 37203, USA. jhainsworth@tnonc.com<br /><searchLink fieldCode="AU" term="%22Burris+HA+3rd%22">Burris HA 3rd</searchLink><br /><searchLink fieldCode="AU" term="%22Billings+FT+3rd%22">Billings FT 3rd</searchLink><br /><searchLink fieldCode="AU" term="%22Bradof+JE%22">Bradof JE</searchLink><br /><searchLink fieldCode="AU" term="%22Baker+M%22">Baker M</searchLink><br /><searchLink fieldCode="AU" term="%22Greco+FA%22">Greco FA</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220374236%22">Cancer</searchLink> [Cancer] 2001 Nov 01; Vol. 92 (9), pp. 2391-8. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0374236 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>0008-543X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220008543X%22">0008543X </searchLink><i>NLM ISO Abbreviation: </i>Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=11745295 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/1097-0142(20011101)92:9<2391::aid-cncr1587>3.0.co;2-m Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2391 Titles: – TitleFull: Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research Network. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hainsworth JD – PersonEntity: Name: NameFull: Burris HA 3rd – PersonEntity: Name: NameFull: Billings FT 3rd – PersonEntity: Name: NameFull: Bradof JE – PersonEntity: Name: NameFull: Baker M – PersonEntity: Name: NameFull: Greco FA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2001 Nov 01 Type: published Y: 2001 Identifiers: – Type: issn-print Value: 0008-543X Numbering: – Type: volume Value: 92 – Type: issue Value: 9 Titles: – TitleFull: Cancer Type: main |
| ResultId | 1 |
